Altria Introduces SWIC: Innovative Tobacco Heating Device in UK

Dec.16.2024
Altria Introduces SWIC: Innovative Tobacco Heating Device in UK
Altria introduces new SWIC tobacco device in UK, offering online sales of innovative heating technology for KETLEpod.

According to Tobacco Insider on December 13th, Altria has begun test market sales of its new heated tobacco device SWIC in the UK. The sales are being conducted through online channels.

Altria Introduces SWIC: Innovative Tobacco Heating Device in UK
Heating tobacco device SWIC | Image source: Tobacco Insider


According to the company, the SWIC device is used in conjunction with KETLEpods and can be used 14 times per charge. The device is equipped with vibration feedback functionality and a screen to display battery level and remaining pod quantity. The SWIC starter kit is priced at £14.49 and includes one device and three boxes of corresponding pod products (each box contains 15 pods in gold, red, and green). Purchasing a single box separately costs £3.49, while 20 boxes are priced at £59.80. Each pod is for disposable use.

Altria Introduces SWIC: Innovative Tobacco Heating Device in UK
Tobacco heating device SWIC | Image source: Tobacco Insider


KETLEpod offers three flavors: Gold, Red, and Green. KETLE Gold provides a balanced tobacco flavor with each pod containing 0.5mg of nicotine. KETLE Red offers a rich tobacco flavor with each pod containing 0.7mg of nicotine. KETLE Green is a blend of tobacco and mint flavors, with each pod also containing 0.7mg of nicotine.


The SWIC device is manufactured by HelixSweden, a subsidiary of Altria, using HeatGrid heating technology. Altria first announced the development of the SWIC device in the spring of 2023, claiming it to be the first heated tobacco device to use filled tobacco pods.


Altria claims that consumers find the concept of SWIC products innovative and unique, and believe that the device is simpler and more user-friendly compared to other heated tobacco products like IQOS.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
Kansas Lawmakers Hear SB 355 to License E-Cigarette Makers, Citing Illicit China Imports
Kansas Lawmakers Hear SB 355 to License E-Cigarette Makers, Citing Illicit China Imports
Kansas lawmakers held a Senate committee hearing on Senate Bill 355 on Jan. 27. The proposal would require e-cigarette manufacturers—potentially affecting distributors as well—to obtain a state license, expanding oversight beyond retailers.
Jan.28 by 2FIRSTS.ai
Product | VOZOL’s New E-Cigarette Appears on Middle East Social Media, Touted at 40,000 Puffs with Dual Mesh Coils and Dual Modes
Product | VOZOL’s New E-Cigarette Appears on Middle East Social Media, Touted at 40,000 Puffs with Dual Mesh Coils and Dual Modes
VOZOL has recently promoted its MAGIC FLEX 40000 e-cigarette on its official Iraq social media account, using mainly Arabic-language posts and listing Baghdad as the account location. The campaign highlights a detachable/separate battery, the ability to switch flavors at will, ECO/POWER dual-mode operation, and a display-based user interface.
Jan.27 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
NYC makers turn discarded disposable vapes into “Vape Synth” mini digital instruments
NYC makers turn discarded disposable vapes into “Vape Synth” mini digital instruments
The report says disposable vapes are sold at more than 11 million units per month and often end up in landfills after flavored nicotine juice runs out, along with lithium-ion batteries, microcontrollers, and LEDs, increasing the risk of waste fires. A New York City maker trio known as Paper Bag Team has built “Vape Synth” by cracking open spent Elf Bar cartridges—specifically the EB BC5000—and hacking them into tiny digital instruments.
Feb.12 by 2FIRSTS.ai
Arizona Moves to Tighten Vape Supply-Chain Enforcement, Targeting Illicit Products
Arizona Moves to Tighten Vape Supply-Chain Enforcement, Targeting Illicit Products
Arizona state Sen. Shawnna Bolick introduced SB 1397 to curb illicit vapes by tracing product origins, intercepting illegal shipments, and cracking down on retailers that violate state law. The proposal would require manufacturers to hold a state license to sell in Arizona, with fines up to $10,000 for unlicensed sales.
Jan.30 by 2FIRSTS.ai